¡Ø Ãß¼® ¿¬ÈÞ ÈÞ¹«¾È³» : 2024³â 9¿ù 16ÀÏ(¿ù) ~ 2024³â 9¿ù 18ÀÏ(¼ö)

½ÃÀ庸°í¼­
»óÇ°ÄÚµå
1509233

°æÇÇÀû Àü±â½Å°æÀÚ±Ø ½ÃÀå : Á¦Ç° À¯Çüº°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚ À¯Çüº°, Áö¿ªº°

Transcutaneous Electrical Nerve Stimulation Market, By Product Type, By Application Type, By End-user Type, By Geography

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Coherent Market Insights | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óÇ°Àº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°è °æÇÇÀû Àü±â½Å°æÀÚ±Ø ½ÃÀåÀº 2024³â 39¾ï 1,000¸¸ ´Þ·¯·Î 2024³âºÎÅÍ 2031³â±îÁö ¿¬Æò±Õ 4.2% ¼ºÀåÇÏ¿© 2031³â¿¡´Â 52¾ï 3,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

±×¸² 1. °æÇÇÀû Àü±â½Å°æÀÚ±Ø ½ÃÀå Á¡À¯À²(%), Áö¿ªº°, 2024³â
Transcutaneous Electrical Nerve Stimulation Market-IMG1

°æÇÇÀû Àü±â½Å°æÀÚ±Ø(TENS)Àº ¼ÒÇü ¹èÅ͸®·Î ÀÛµ¿µÇ´Â ÀåÄ¡¿¡¼­ ¹ß»ýÇÏ´Â Àü·ù¸¦ ÀÌ¿ëÇÏ¿© ½Å°æÀ» ÀÚ±ØÇÏ¿© ÅëÁõÀ» ¿ÏÈ­ÇÏ´Â ºñħ½ÀÀû ¹æ¹ýÀÔ´Ï´Ù. TENS ±â°è´Â ÀϹÝÀûÀ¸·Î ±Ù°ñ°Ý°è ÅëÁõ, ½Å°æº´Áõ¼º ÅëÁõ, ¼ö¼ú ÈÄ ¹× ºÐ¸¸°ú °°Àº ±Þ¼º ¹× ¸¸¼º ÅëÁõ »óÅ¿¡ »ç¿ëµË´Ï´Ù. ¼¼°è TENS ½ÃÀåÀº Á¤Çü¿Ü°ú Áúȯ°ú ±×¿¡ µû¸¥ ÅëÁõ¿¡ Ãë¾àÇÑ ³ëÀÎ Àα¸ÀÇ Áõ°¡, ºñ¾à¹° ¿ä¹ý¿¡ ´ëÇÑ È¯ÀÚ ¼±È£µµ Áõ°¡, ÅëÁõ °ü¸®¸¦ À§ÇÑ ¿þ¾î·¯ºí ±â±â äÅà Ȯ´ë µîÀÇ ¿äÀÎÀ¸·Î ÀÎÇØ ÃÖ±Ù ¸î ³â µ¿¾È ¾ÈÁ¤ÀûÀÎ ¼ºÀå¼¼¸¦ º¸ÀÌ°í ÀÖ½À´Ï´Ù.

½ÃÀå ¿ªÇÐ:

°æÇÇÀû Àü±â½Å°æÀÚ±Ø ¼¼°è ½ÃÀåÀº ¸¸¼º ÅëÁõ¿¡ Ãë¾àÇÑ ³ëÀÎ Àα¸ÀÇ Áõ°¡, ½Å°æº´Áõ ¹× ±Ù°ñ°Ý°è ÁúȯÀÇ À¯º´·ü Áõ°¡, ºñ¾à¹°Àû ÅëÁõ Ä¡·á¹ý¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡·Î ÀÎÇØ ¼ºÀåÇÏ°í ÀÖ½À´Ï´Ù. ±×·¯³ª ¾à¹° ±â¹Ý ´ëü ¿ä¹ýÀÇ °¡¿ë¼º, ÀÓ»óÀû À¯È¿¼º µ¥ÀÌÅÍ ºÎÁ·, ºí·çÅõ½º ¿¬°áÀ» ÅëÇÑ ¿ø°Ý ¸ð´ÏÅ͸µÀÌ °¡´ÉÇÑ µðÁöÅÐ TENS ±â±âÀÇ µîÀåÀº ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÏ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ÀÌ´Â À¯¸®ÇÑ ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. ÅëÁõ °­µµ¿¡ µû¸¥ ¸ÂÃãÇü Ä¡·á¸¦ À§ÇØ AI¿Í °°Àº ±â¼ú°ú ÅëÇÕµÈ ¿þ¾î·¯ºí TENS ±â±âÀÇ Çõ½Åµµ À¯¸ÁÇÕ´Ï´Ù.

º» Á¶»çÀÇ ÁÖ¿ä Ư¡

  • ÀÌ º¸°í¼­´Â Àü ¼¼°è °æÇÇÀû Àü±â½Å°æÀÚ±Ø ½ÃÀåÀ» »ó¼¼È÷ ºÐ¼®ÇÏ°í 2023³âÀ» ±âÁØ ¿¬µµ·Î ÇÏ¿© ¿¹Ãø ±â°£(2024-2031³â) µ¿¾È ½ÃÀå ±Ô¸ð(10¾ï ´Þ·¯)¿Í ¿¬Æò±Õ ¼ºÀå·ü(CAGR)À» ¿¹ÃøÇÏ°í ÀÖ½À´Ï´Ù.
  • ¶ÇÇÑ ´Ù¾çÇÑ ºÎ¹®¿¡ °ÉÄ£ ÀáÀçÀû ¼öÀÍ ¼ºÀå ±âȸ¸¦ ¹àÈ÷°í, ÀÌ ½ÃÀåÀÇ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾È ¸ÅÆ®¸¯½º¸¦ ¼³¸íÇÕ´Ï´Ù.
  • ¶ÇÇÑ ½ÃÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç° Ãâ½Ã ¹× ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ªº° Àü¸Á, ÁÖ¿ä ±â¾÷ÀÌ Ã¤ÅÃÇÑ °æÀï Àü·« µî¿¡ ´ëÇÑ ÁÖ¿ä ÀλçÀÌÆ®µµ Á¦°øÇÕ´Ï´Ù.
  • ÀÌ º¸°í¼­´Â ±â¾÷ ÇÏÀ̶óÀÌÆ®, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿ä ÇÏÀ̶óÀÌÆ®, À繫 ¼º°ú ¹× Àü·«°ú °°Àº ¸Å°³ º¯¼ö¸¦ ±â¹ÝÀ¸·Î ¼¼°è °æÇÇÀû Àü±â½Å°æÀÚ±Ø ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷À» ÇÁ·ÎÆÄÀϸµÇÕ´Ï´Ù.
  • ÀÌ º¸°í¼­ÀÇ ÀλçÀÌÆ®¸¦ ÅëÇØ ¸¶ÄÉÆà ´ã´çÀÚ¿Í ±â¾÷ °æ¿µÁøÀº ÇâÈÄ Á¦Ç° Ãâ½Ã, À¯Çü ¾÷±×·¹À̵å, ½ÃÀå È®´ë ¹× ¸¶ÄÉÆà Àü¼ú¿¡ ´ëÇÑ Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖÀ» °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.
  • ¼¼°è °æÇÇÀû Àü±â½Å°æÀÚ±Ø ½ÃÀå º¸°í¼­´Â ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë¾÷ü, ½Å±Ô ÁøÀÔÀÚ, À繫 ºÐ¼®°¡ µî ÀÌ ¾÷°èÀÇ ´Ù¾çÇÑ ÀÌÇØ°ü°èÀÚ¸¦ ´ë»óÀ¸·Î ÇÕ´Ï´Ù.
  • ÀÌÇØ°ü°èÀÚµéÀº ¼¼°è °æÇÇÀû Àü±â½Å°æÀÚ±Ø ½ÃÀå ºÐ¼®¿¡ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÇ»ç°áÁ¤À» ¿ëÀÌÇÏ°Ô ÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¸ñÀû°ú °¡Á¤

  • Á¶»ç ¸ñÀû
  • °¡Á¤
  • ¾à¾î

Á¦2Àå ½ÃÀå Àü¸Á

  • º¸°í¼­ ¼³¸í
    • ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§
  • ÁÖ¿ä ¿ä¾à
  • Coherent Opportunity Map(COM)

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
  • ¿µÇ⠺м®
  • ½ÃÀå µ¿Çâ
  • ÁÖ¿ä ¹ßÀü
  • ±ÔÁ¦ ½Ã³ª¸®¿À
  • Àμö¿Í Á¦ÈÞ ½Ã³ª¸®¿À
  • ÀÚ±Ý Á¶´Þ°ú ÅõÀÚ
  • PEST ºÐ¼®
  • Porters ºÐ¼®

Á¦4Àå ¼¼°èÀÇ °æÇÇÀû Àü±â½Å°æÀÚ±Ø ½ÃÀå - Äڷγª¹ÙÀÌ·¯½º(COVID-19) ÆÒµ¥¹ÍÀÇ ¿µÇâ

  • ÀüüÀûÀÎ ¿µÇâ
  • Á¤ºÎ À̴ϼÅƼºê
  • COVID-19ÀÇ ½ÃÀå¿¡ ´ëÇÑ ¿µÇâ

Á¦5Àå ¼¼°èÀÇ °æÇÇÀû Àü±â½Å°æÀÚ±Ø ½ÃÀå, Á¦Ç° À¯Çüº°, 2019-2031³â(10¾ï ´Þ·¯)

  • ÈÞ´ë¿ë TENS
  • Å×À̺íÅé TENS

Á¦6Àå ¼¼°èÀÇ °æÇÇÀû Àü±â½Å°æÀÚ±Ø ½ÃÀå, ¿ëµµ À¯Çüº°, 2019-2031³â(10¾ï ´Þ·¯)

  • ¸¸¼º ÅëÁõ
  • ±Þ¼º ÅëÁõ

Á¦7Àå ¼¼°èÀÇ °æÇÇÀû Àü±â½Å°æÀÚ±Ø ½ÃÀå, ÃÖÁ¾»ç¿ëÀÚ À¯Çüº°, 2019-2031³â(10¾ï ´Þ·¯)

  • º´¿ø
  • ¹°¸®Ä¡·á Ŭ¸®´Ð
  • ÀçÈ° ¼¾ÅÍ
  • ȨÄɾî
  • ±âŸ

Á¦8Àå ¼¼°èÀÇ °æÇÇÀû Àü±â½Å°æÀÚ±Ø ½ÃÀå, Áö¿ªº°, 2019-2031³â(10¾ï ´Þ·¯)

  • ¶óƾ¾Æ¸Þ¸®Ä«
  • À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
  • Áßµ¿

Á¦9Àå °æÀï »óȲ

  • ±â¾÷ °³¿ä
    • Medtronic plc
    • 3D Systems
    • Abbott Laboratories
    • Boston Scientific Corporation
    • Omron Healthcare, Inc.
    • Nevro Corp.
    • DJO Global, Inc.
    • Zynex Medical
    • COMPex
    • ITO Co., Ltd.
    • Beurer GmbH
    • BTL
    • Chattanooga International
    • EMS Physio Ltd.
    • BioMedical Life Systems, Inc.
    • Current Solutions, LLC
    • Zewa, Inc.
    • Walgreen Co.
    • Pain Management Technologies, Inc.
    • OPTP
    • Roscoe Medical

Á¦10Àå ¾Ö³Î¸®½ºÆ®ÀÇ Á¦¾È

  • Wheel of Fortune
  • ¾Ö³Î¸®½ºÆ®ÀÇ °ßÇØ
  • Coherent Opportunity Map

Á¦11Àå Âü°í¹®Çå°ú Á¶»ç ¹æ¹ý

  • Âü°í¹®Çå
  • Á¶»ç ¹æ¹ý
ksm 24.07.12

The global Transcutaneous Electrical Nerve Stimulation Market is estimated to be valued at USD 3.91 Bn in 2024 and is expected to reach USD 5.23 Bn by 2031, growing at a compound annual growth rate (CAGR) of 4.2% from 2024 to 2031.

Figure 1. Transcutaneous Electrical Nerve Stimulation Market Share (%), By Region, 2024
Transcutaneous Electrical Nerve Stimulation Market - IMG1

Transcutaneous electrical nerve stimulation (TENS) is a non-invasive method of using electric current produced by a small, battery-powered device to stimulate the nerves for pain relief. It helps relieve pain by interrupting the pain signals sent to the brain and causes the body to produce endogenous opioids that also help suppress pain. TENS machines are commonly used for acute and chronic pain conditions such as musculoskeletal pain, neuropathic pain, and postoperative and labor pain. The global TENS market has been growing at a steady pace in recent years owing to factors such as rising geriatric population prone to orthopedic conditions and associated pain, increasing preference for non-drug therapies among patients, and growing adoption of wearable devices for pain management.

Market Dynamics:

The global transcutaneous electrical nerve stimulation market is driven by the rising geriatric population worldwide prone to chronic pain conditions, growing prevalence of neuropathic and musculoskeletal disorders, and increasing need for non-drug pain therapies. However, availability of alternative drug-based therapies and lack of clinical efficacy data are some of the factors expected to restrain the market growth. Emergence of digital TENS devices with Bluetooth connectivity for remote monitoring presents lucrative opportunities. Innovation of wearable TENS devices integrated with technologies like AI for customized treatment based on pain intensity also holds promise.

Key Features of the Study:

  • This report provides an in-depth analysis of the global transcutaneous electrical nerve stimulation market and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global transcutaneous electrical nerve stimulation market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include DJO, LLC, NeuroMetrix, Inc., Uroplasty, Inc., Zynex Medical, and Bioness, Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global transcutaneous electrical nerve stimulation market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global transcutaneous electrical nerve stimulation market

Detailed Segmentation-

  • By Product Type
    • Portable TENS
    • Table Top TENS
  • By Application Type
    • Chronic Pain
    • Acute Pain
  • By End User
    • Hospitals
    • Physiotherapy Clinics
    • Rehabilitation Centers
    • Home care
    • Others
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • Medtronic plc
    • Abbott Laboratories
    • Boston Scientific Corporation
    • Omron Healthcare, Inc.
    • Nevro Corp.
    • DJO Global, Inc.
    • Zynex Medical
    • COMPex
    • ITO Co., Ltd.
    • Beurer GmbH
    • BTL
    • Chattanooga International
    • EMS Physio Ltd.
    • BioMedical Life Systems, Inc.
    • Current Solutions, LLC
    • Zewa, Inc.
    • Walgreen Co.
    • Pain Management Technologies, Inc.
    • OPTP
    • Roscoe Medical

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Product Type
    • Market Snapshot, By Application Type
    • Market Snapshot, By End-user Type
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Regulatory Scenario
  • Acquisitions and Partnerships Scenario
  • Funding and Investments
  • PEST Analysis
  • Porter's Analysis

4. Global Transcutaneous Electrical Nerve Stimulation Market - Impact of Coronavirus (COVID-19) Pandemic

  • Overall Impact
  • Government Initiatives
  • COVID-19 Impact on the Market

5. Global Transcutaneous Electrical Nerve Stimulation Market, By Product Type, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Portable TENS
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Table Top TENS
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Transcutaneous Electrical Nerve Stimulation Market, By Application Type, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Chronic Pain
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Acute Pain
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Transcutaneous Electrical Nerve Stimulation Market, By End-user Type, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Hospitals
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Physiotherapy Clinics
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Rehabilitation Centers
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Home care
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Transcutaneous Electrical Nerve Stimulation Market, By Region, 2019 - 2031, (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, For Region, 2020-2031
    • Regional Trends
      • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End-user Type 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Therapy, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End-user Type 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Therapy, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End-user Type 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Therapy, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End-user Type 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Therapy, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End-user Type 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • GCC
      • Israel
      • Rest of Middle East
      • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Therapy, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End-user Type 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
      • North Africa
      • Central Africa
      • South Africa

9. Competitive Landscape

  • Company Profiles
    • Medtronic plc
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • 3D Systems
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Abbott Laboratories
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Boston Scientific Corporation
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Omron Healthcare, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Nevro Corp.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • DJO Global, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Zynex Medical
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • COMPex
    • ITO Co., Ltd.
    • Beurer GmbH
    • BTL
    • Chattanooga International
    • EMS Physio Ltd.
    • BioMedical Life Systems, Inc.
    • Current Solutions, LLC
    • Zewa, Inc.
    • Walgreen Co.
    • Pain Management Technologies, Inc.
    • OPTP
    • Roscoe Medical

10. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. References and Research Methodology

  • References
  • Research Methodology
  • About Us and Sales Contact
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óÇ°À» ¼±Åà Áß
»óÇ° ºñ±³Çϱâ
Àüü»èÁ¦